Doxofylline supplier | CasNO.69975-86-6

Name
Doxofylline
EINECS 274-239-6
CAS No. 69975-86-6
Article Data11
CAS DataBase
Density 1.59 g/cm³
Solubility soluble in water
Melting Point 144-146 °C
Formula C₁₁H₁₄N₄O₄
Boiling Point 505.2 °C at 760 mmHg
Molecular Weight 266.257
Flash Point 259.3 °C
Transport Information
Appearance
Safety 26-36/37
Risk Codes 36/37/38
Molecular Structure
Hazard Symbols Xi
Synonyms Theophylline,7-(1,3-dioxolan-2-ylmethyl)- (7CI);2-(7'-Theophyllinemethyl)-1,3-dioxolane;ABC 12/3;ABC 1213;Ansimar;Dioxyfilline;Doxophylline;Maxivent;Ventax;1H-purine-2,6-dione, 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-;7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione;Doxofylline;
PSA 80.28000
LogP -1.19340

Doxofylline Specification

1. Introduction of Doxofylline

The Doxofylline, with the CAS registry number 69975-86-6 and EINECS registry number 274-239-6, has the systematic name of 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione. It is a xanthine derivative drug used in the treatment of asthma. The molecular formula of this chemical is C₁₁H₁₄N₄O₄.

2.The properties of Doxofylline

(1)ACD/LogP: -0.70; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.7; (4)ACD/LogD (pH 7.4): -0.7; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 9.89; (8)ACD/KOC (pH 7.4): 9.89; (9)#H bond acceptors: 8; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 76.9 Å²; (13)Index of Refraction: 1.7; (14)Molar Refractivity: 64.62 cm³; (15)Molar Volume: 167.1 cm³; (16)Polarizability: 25.61×10^-24cm³; (17)Surface Tension: 63.3 dyne/cm; (18)Density: 1.59 g/cm³; (19)Flash Point: 259.3 °C; (20)Enthalpy of Vaporization: 77.48 kJ/mol; (21)Boiling Point: 505.2 °C at 760 mmHg; (22)Vapour Pressure: 2.49E-10 mmHg at 25°C.

3. Structure descriptors of Doxofylline

(1)SMILES: O=C2c1n(cnc1N(C(=O)N2C)C)CC3OCCO3
(2)InChI: InChI=1/C11H14N4O4/c1-13-9-8(10(16)14(2)11(13)17)15(6-12-9)5-7-18-3-4-19-7/h6-7H,3-5H2,1-2H3
(3)InChIKey: HWXIGFIVGWUZAO-UHFFFAOYAA

4.Safety information of Doxofylline

It irritates eyes, respiratory system and skin. Therefore, you had better take the following instructions: Wear suitable protective clothing and gloves, and in case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.

5.The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Source
mouse	LD50	intraperitoneal	396mg/kg (396mg/kg)	United States Patent Document. Vol. #4187308,
mouse	LD50	intravenous	216mg/kg (216mg/kg)	Farmaco, Edizione Scientifica. Vol. 36, Pg. 201, 1981.
mouse	LD50	oral	841mg/kg (841mg/kg)	Farmaco, Edizione Scientifica. Vol. 36, Pg. 201, 1981.
rat	LD50	intraperitoneal	426mg/kg (426mg/kg)	United States Patent Document. Vol. #4187308,
rat	LD50	intravenous	315mg/kg (315mg/kg)	United States Patent Document. Vol. #4187308,
rat	LD50	oral	965mg/kg (965mg/kg)	United States Patent Document. Vol. #4868186,

Product Name

Doxofylline

Doxofylline Specification

Related Products

Hot Products